Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Haematologica - Tập 104 Số 2 - Trang e68-e71 - 2019
Toby A. Eyre1, Harriet S. Walter2, Sunil Iyengar3, George Follows4, Matthew Cross3, Christopher P. Fox5, Andrew Hodson6, Josh T. Coats7, Santosh Narat8, Nicholas Morley6, Martin J.S. Dyer2, Graham P. Collins1
1Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
2The Ernest and Helen Scott Haematological Research Institute, University of Leicester
3Department of Haematology, The Royal Marsden Hospital, London
4Department of Haematology, Addenbrooke’s Hospital NHS Trust, Cambridge
5Department of Haematology, Nottingham University Hospitals NHS Trust
6Department of Haematology, Ipswich Hospital
7Department of Haematology, NHS Tayside, Dundee
8Department of Haematology, Western Sussex Hospitals NHS Foundation Trust, Worthing

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Haematologica

Tập 104 Số 2

e68-e71

Thông tin tác giả